Cambrios gets license for bio-based electronics work

Nov. 3, 2004 – Cambrios Technologies Corp. has been granted a license to technology that it considers integral to developing a biologically based platform for the electronics industry, according to a news release.

The Cambridge, Mass.-based firm, which plans by year’s end to move primary operations to Palo Alto, Calif., said the deal includes an option to maintain an exclusive license to Dyax Corp.’s peptide phage display technology for synthesizing and assembling materials and structures used in electronic applications. Dyax scientists in the late 1980s discovered and patented bacteriophage display technology, which is used in drug discovery, diagnostic imaging and other biological areas. Bacteriophage, or phage is a virus that infects only bacteria.

Cambrios co-founder Angela Belcher saw the potential for using phage techniques to synthesize self-assembling nanostructures.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.

Leave a Reply

Your email address will not be published. Required fields are marked *


KLA-Tencor announces new defect inspection systems
07/12/2018KLA-Tencor Corporation announced two new defect inspection products at SEMICON West this week, addressing two key challenges in tool and process monit...
3D-Micromac unveils laser-based high-volume sample preparation solution for semiconductor failure analysis
07/09/2018microPREP 2.0 provides order of magnitude time and cost savings compared to traditional sample...
Leak check semiconductor process chambers quickly and reliably
02/08/2018INFICON,a manufacturer of leak test equipment, introduced the UL3000 Fab leak detector for semiconductor manufacturing maintenance teams t...